Dr. Herrmann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Interventional Cardiology, 2010 - 2011
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 2006 - 2010
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2003 - 2006
- Ruhr - University Bochum Faculty of MedicineClass of 1997
Certifications & Licensure
- IA State Medical License 2014 - 2025
- WI State Medical License 2014 - 2025
- MN State Medical License 2005 - 2024
- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- TrAstuzumab Cardiomyopathy Therapeutic Intervention With Carvedilol Start of enrollment: 2019 Aug 21
- Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial Start of enrollment: 2020 Sep 01
Publications & Presentations
PubMed
- 251 citationsEvaluation and Management of Patients With Heart Disease and Cancer: Cardio-OncologyJoerg Herrmann, Amir Lerman, Nicole P. Sandhu, Hector R. Villarraga, Sharon L. Mulvagh
Mayo Clinic Proceedings. 2014-09-01 - 333 citationsAdverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmiaJoerg Herrmann
Nature Reviews. Cardiology. 2020-03-30 - 235 citations5-fluorouracil and cardiotoxicity: a reviewJaskanwal D. Sara, Jasvinder Kaur, Ryan Khodadadi, Muneeb Rehman, Ronstan Lobo
Therapeutic Advances in Medical Oncology. 2018-06-18
Lectures
- 10th Annual Mayo Clinic Interventional Cardiology Board ReviewMayo School of Continuous Professional Development, Rochester, Minnesota - 9/27/2013
- 10th Annual Mayo Clinic Interventional Cardiology Board ReviewMayo School of Continuous Professional Development, Rochester, Minnesota - 9/27/2013
Press Mentions
- CV Admissions on the Rise in Americans with CancerAugust 9th, 2022
- In Neurodegenerative Diseases, Research Finds Shared Gene Patterns, Widespread DamageFebruary 2nd, 2022
- Time Tempers Anthracyclines into a Toxin or Treatment for CancerJanuary 31st, 2022
- Join now to see all
Professional Memberships
- Member
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: